The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Standardized radiofrequency ablation (sRFA) ≥ 45 minutes (m) plus lyso-thermosensitive liposomal doxorubicin (LTLD) for solitary hepatocellular carcinoma (HCC) lesions 3-7 cm: A retrospective analysis of phase III HEAT study.
Riccardo Lencioni
Consultant or Advisory Role - Celsion Corporation
Research Funding - Celsion Corporation
Won-Young Tak
Research Funding - Celsion Corporation
Min Hua Chen
Research Funding - Celsion Corporation
Richard S. Finn
Research Funding - Celsion Corporation
Morris Sherman
Research Funding - Celsion Corporation
Lukas Makris
Consultant or Advisory Role - Celsion Corporation
Micheal O'Neal
Consultant or Advisory Role - Celsion Corporation
William Simonich
Consultant or Advisory Role - Celsion Corporation
Dieter Haemmerich
Consultant or Advisory Role - Celsion Corporation
Robert Reed
Employment or Leadership Position - Celsion Corporation
Stock Ownership - Celsion Corporation
Nicholas Borys
Employment or Leadership Position - Celsion Corporation
Stock Ownership - Celsion Corporation
Ronnie Tung Ping Poon
Research Funding - Celsion Corporation
Ghassan K. Abou-Alfa
Consultant or Advisory Role - Celsion Corporation